{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:07Z","timestamp":1791576127595,"version":"4.3.4"},"reference-count":55,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The interaction of platelet glycoprotein Ib\u03b1 (GPIb\u03b1) with von Willebrand factor (VWF) initiates hemostasis after vascular injury and also contributes to pathological thrombosis. GPIb\u03b1 binding to the VWF A1 domain (VWFA1) is a target for antithrombotic intervention, but attempts to develop pharmacologic inhibitors have been hindered by the lack of animal models because of the species specificity of the interaction. To address this problem, we generated a knockin mouse with Vwf exon 28\u2013encoding domains A1 and A2 replaced by the human homolog (VWFh28). VWFh28 mice (M1HA) were crossbred with a transgenic mouse strain expressing human GPIb\u03b1 on platelets (mGPIb\u03b1null;hGPIb\u03b1Tg; H1MA) to generate a new strain (H1HA) with humanized GPIb\u03b1-VWFA1 binding. Plasma VWF levels in the latter 3 strains were similar to those of wild-type mice (M1MA). Compared with the strains that had homospecific GPIb\u03b1-VWF pairing (M1MA and H1HA), M1HA mice of those with heterospecific pairing had a markedly greater prolongation of tail bleeding time and attenuation of thrombogenesis after injury to the carotid artery than H1MA mice. Measurements of GPIb\u03b1-VWFA1 binding affinity by surface plasmon resonance agreed with the extent of observed functional defects. Ristocetin-induced platelet aggregation was similar in H1HA mouse and human platelet-rich plasma, and it was comparably inhibited by monoclonal antibody NMC-4, which is known to block human GPIb\u03b1-VWFA1 binding, which also inhibited FeCl3-induced mouse carotid artery thrombosis. Thus, the H1HA mouse strain is a fully humanized model of platelet GPIb\u03b1-VWFA1 binding that provides mechanistic and pharmacologic information relevant to human hemostatic and thrombotic disorders.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018023507","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T15:45:39Z","timestamp":1538667939000},"page":"2522-2532","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":24,"title":["Humanized GPIb\u03b1\u2013von Willebrand factor interaction in the mouse"],"prefix":"10.1182","volume":"2","author":[{"given":"Sachiko","family":"Kanaji","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Orje","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Kanaji","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kamikubo","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Morodomi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zarpellon","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2974-7541","authenticated-orcid":false,"given":"Jerome","family":"Eberhardt","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5964-7111","authenticated-orcid":false,"given":"Stefano","family":"Forli","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot A.","family":"Fahs","sequence":"additional","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"},{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"},{"name":"Children\u2019s Research Institute, Children\u2019s Hospital of Wisconsin, Milwaukee, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"},{"name":"Division of Pediatric Pathology, Department of Pathology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Haberichter","sequence":"additional","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"},{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"},{"name":"Children\u2019s Research Institute, Children\u2019s Hospital of Wisconsin, Milwaukee, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"},{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"},{"name":"Children\u2019s Research Institute, Children\u2019s Hospital of Wisconsin, Milwaukee, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaverio M.","family":"Ruggeri","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, MERU-Roon Research Center on Vascular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"issue":"10","key":"2020021108374062000_B1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/jth.12698","article-title":"Thrombosis: a major contributor to the global disease burden","volume":"12","author":"ISTH Steering Committee for World Thrombosis Day","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2020021108374062000_B2","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest"},{"issue":"11","key":"2020021108374062000_B3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"issue":"11","key":"2020021108374062000_B4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.2515","article-title":"Arterial thrombosis--insidious, unpredictable and deadly","volume":"17","author":"Jackson","year":"2011","journal-title":"Nat Med"},{"issue":"22","key":"2020021108374062000_B5","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"issue":"20","key":"2020021108374062000_B6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"2020021108374062000_B7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0002-9149(00)00722-0","article-title":"Antithrombotic effects of abciximab","volume":"85","author":"Hayes","year":"2000","journal-title":"Am J Cardiol"},{"issue":"7329","key":"2020021108374062000_B8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"issue":"12","key":"2020021108374062000_B9","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/01.RES.0000267878.97021.ab","article-title":"Adhesion mechanisms in platelet function","volume":"100","author":"Ruggeri","year":"2007","journal-title":"Circ Res"},{"issue":"3","key":"2020021108374062000_B10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5482\/HAMO-14-12-0081","article-title":"Interaction of von Willebrand factor with platelets and the vessel wall","volume":"35","author":"Ruggeri","year":"2015","journal-title":"Hamostaseologie"},{"issue":"26","key":"2020021108374062000_B11","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.2174\/138161207781662867","article-title":"Inhibition of platelet glycoprotein Ib and its antithrombotic potential","volume":"13","author":"Vanhoorelbeke","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"4","key":"2020021108374062000_B12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2174\/1570161111311040008","article-title":"Von Willebrand factor and thrombosis: risk factor, actor and pharmacological target","volume":"11","author":"Lenting","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"2020021108374062000_B13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/bcmd.1997.0146","article-title":"Cloning of the murine platelet glycoprotein Ibalpha gene highlighting species-specific platelet adhesion","volume":"23","author":"Ware","year":"1997","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"2020021108374062000_B14","doi-asserted-by":"crossref","first-page":"8376","DOI":"10.1016\/S0021-9258(18)53105-7","article-title":"Expression of human platelet glycoprotein Ib alpha in transgenic mice","volume":"268","author":"Ware","year":"1993","journal-title":"J Biol Chem"},{"issue":"6","key":"2020021108374062000_B15","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1073\/pnas.050582097","article-title":"Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome","volume":"97","author":"Ware","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020021108374062000_B16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nbt1373","article-title":"Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies","volume":"26","author":"Chen","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"13","key":"2020021108374062000_B17","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood-2012-03-420042","article-title":"A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor","volume":"120","author":"Navarrete","year":"2012","journal-title":"Blood"},{"issue":"21","key":"2020021108374062000_B18","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.1017042108","article-title":"Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I","volume":"108","author":"Zarpellon","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2020021108374062000_B19","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2006-04-011551","article-title":"Activation-independent platelet adhesion and aggregation under elevated shear stress","volume":"108","author":"Ruggeri","year":"2006","journal-title":"Blood"},{"issue":"3","key":"2020021108374062000_B20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/mt.2011.231","article-title":"Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy","volume":"20","author":"Kanaji","year":"2012","journal-title":"Mol Ther"},{"issue":"8","key":"2020021108374062000_B21","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2012.04797.x","article-title":"Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis","volume":"10","author":"Kanaji","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2020021108374062000_B22","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1538-7836.2006.02086.x","article-title":"Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis","volume":"4","author":"Konstantinides","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"14","key":"2020021108374062000_B23","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood-2017-02-767079","article-title":"Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex","volume":"130","author":"Kamikubo","year":"2017","journal-title":"Blood"},{"issue":"33","key":"2020021108374062000_B24","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"issue":"7","key":"2020021108374062000_B25","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1172\/JCI46129","article-title":"P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice","volume":"121","author":"Furlan-Freguia","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"2020021108374062000_B26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V77.1.113.113","article-title":"Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib","volume":"77","author":"Fujimura","year":"1991","journal-title":"Blood"},{"issue":"3","key":"2020021108374062000_B27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nsb0398-189","article-title":"Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab","volume":"5","author":"Celikel","year":"1998","journal-title":"Nat Struct Biol"},{"issue":"1","key":"2020021108374062000_B28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/bcmd.1997.0128","article-title":"Crystal structure of NMC-4 fab anti-von Willebrand factor A1 domain","volume":"23","author":"Celikel","year":"1997","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"2020021108374062000_B29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1172\/JCI973","article-title":"Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions","volume":"101","author":"Goto","year":"1998","journal-title":"J Clin Invest"},{"issue":"5 Pt 2","key":"2020021108374062000_B30","first-page":"H1787","article-title":"Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis","volume":"265","author":"Strony","year":"1993","journal-title":"Am J Physiol"},{"issue":"6","key":"2020021108374062000_B31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1115\/1.1318907","article-title":"Maximal wall shear stress in arterial stenoses: application to the internal carotid arteries","volume":"122","author":"Lorthois","year":"2000","journal-title":"J Biomech Eng"},{"issue":"3","key":"2020021108374062000_B32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/iep.12182","article-title":"New approaches in tail-bleeding assay in mice: improving an important method for designing new anti-thrombotic agents","volume":"97","author":"Saito","year":"2016","journal-title":"Int J Exp Pathol"},{"issue":"16","key":"2020021108374062000_B33","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2020021108374062000_B34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood-2010-01-266080","article-title":"A central role of GPIb-IX in the procoagulant function of platelets that is independent of the 45-kDa GPIbalpha N-terminal extracellular domain","volume":"116","author":"Ravanat","year":"2010","journal-title":"Blood"},{"key":"2020021108374062000_B35","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1038\/ncomms15559","article-title":"Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIb\u03b1","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"issue":"8","key":"2020021108374062000_B36","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2005-07-2765","article-title":"Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura","volume":"107","author":"Banno","year":"2006","journal-title":"Blood"},{"issue":"10","key":"2020021108374062000_B37","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J Clin Invest"},{"issue":"9","key":"2020021108374062000_B38","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/jth.13775","article-title":"A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor","volume":"15","author":"Deng","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2020021108374062000_B39","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/ATVBAHA.108.168369","article-title":"Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease","volume":"28","author":"De Meyer","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2020021108374062000_B40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/ATVBAHA.107.159442","article-title":"Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants","volume":"28","author":"Marx","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2020021108374062000_B41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pbc.20658","article-title":"Regulated release of VWF and FVIII and the biologic implications","volume":"46","author":"Haberichter","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2020021108374062000_B42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"issue":"5","key":"2020021108374062000_B43","doi-asserted-by":"crossref","first-page":"e37508","DOI":"10.1371\/journal.pone.0037508","article-title":"In vivo analysis of the role of O-glycosylations of von Willebrand factor","volume":"7","author":"Badirou","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"2020021108374062000_B44","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/STROKEAHA.111.616649","article-title":"The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: a randomized trial","volume":"42","author":"Markus","year":"2011","journal-title":"Stroke"},{"issue":"25","key":"2020021108374062000_B45","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1182\/blood-2012-11-464545","article-title":"Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs","volume":"121","author":"Momi","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2020021108374062000_B46","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1538-7836.2009.03459.x","article-title":"Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779","volume":"7","author":"Diener","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2020021108374062000_B47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2020021108374062000_B48","first-page":"539","article-title":"A dose ranging phase I\/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura","volume":"106","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Thromb Haemost"},{"issue":"9","key":"2020021108374062000_B49","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/ATVBAHA.117.309319","article-title":"A novel single-domain antibody against von Willebrand factor A1 domain resolves leukocyte recruitment and vascular leakage during inflammation-brief report","volume":"37","author":"Aym\u00e9","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2020021108374062000_B50","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1182\/blood.V83.11.3218.3218","article-title":"Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates","volume":"83","author":"Cadroy","year":"1994","journal-title":"Blood"},{"issue":"5","key":"2020021108374062000_B51","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0037-1614136","article-title":"S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis model","volume":"84","author":"Gurevitz","year":"2000","journal-title":"Thromb Haemost"},{"issue":"5","key":"2020021108374062000_B52","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood.V94.5.1693","article-title":"Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: in vitro and ex vivo inhibition of platelet function","volume":"94","author":"Inbal","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2020021108374062000_B53","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/01.CIR.89.6.2822","article-title":"Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs","volume":"89","author":"Yao","year":"1994","journal-title":"Circulation"},{"issue":"6","key":"2020021108374062000_B54","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/01.CIR.90.6.2976","article-title":"Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain","volume":"90","author":"McGhie","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"2020021108374062000_B55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjp.0701354","article-title":"Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor","volume":"122","author":"Kageyama","year":"1997","journal-title":"Br J Pharmacol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/19\/2522\/1629458\/advances023507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/19\/2522\/1629458\/advances023507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T08:40:39Z","timestamp":1662194439000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/19\/2522\/16084\/Humanized-GPIb%CE%B1von-Willebrand-factor-interaction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":55,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,10,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018023507","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,4]]}}}